4.5 Article

Losartan as disease modulating therapy for recessive dystrophic epidermolysis bullosa

Journal

DERMATOLOGIC THERAPY
Volume 33, Issue 6, Pages -

Publisher

WILEY
DOI: 10.1111/dth.14279

Keywords

epidermolysis bullosa; losartan; recessive dystrophic epidermolysis bullosa

Categories

Ask authors/readers for more resources

A 6-year-old child with recessive dystrophic epidermolysis bullosa, confirmed by history, clinical exam, and antigen mapping, was treated with losartan with reduction in the blistering and better quality of life.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available